nach oben

Erschienen in:

19.07.2019 | Original Paper

Recent Incarceration as a Primary Barrier to Virologic Suppression Among Women Living with HIV: Results from a Longitudinal Community-Based Cohort in a Canadian Setting

verfasst von: Margaret Erickson, Neora Pick, Flo Ranville, Melissa Braschel, Mary Kestler, Karen Kinvig, Andrea Krüsi, Kate Shannon, SHAWNA Project

Erschienen in: AIDS and Behavior | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Women living with HIV (WLWH) are disproportionately represented among incarcerated populations yet there is a paucity of research on how incarceration shapes HIV treatment outcomes for women. Data is drawn from SHAWNA (Sexual health and HIV/AIDS: Women’s Longitudinal Needs Assessment), a longitudinal community-based open research cohort with cis and trans WLWH in Metro Vancouver, Canada (2010–2017). Multivariable logistic regression using generalized estimating equations (GEE) longitudinally modeled the effect of incarceration on virologic suppression (HIV plasma VL < 50 copies/mL), adjusting for potential confounders. Amongst 292 WLWH, the majority (74%) had been incarcerated in their lifetime and 17% were incarcerated over the study period. Exposure to recent incarceration was independently correlated with reduced odds of virologic suppression (AOR: 0.42, 95% CI 0.22–0.80). This study suggests critical need for research and interventions to better address factors shaping ART adherence and retention in care for WLWH, both within correctional centres and following release from prison.

Jürgens R, Nowak M, Day M. HIV and incarceration: prisons and detention. J Int AIDS Soc. 2011;14:26.CrossRefPubMedPubMedCentral

Rubenstein LS, Amon JJ, McLemore M, Eba P, Dolan K, Lines R, et al. HIV, prisoners, and human rights. Lancet. 2016;388(10050):1202–14.CrossRefPubMed

Uthman OA, Oladimeji O, Nduka C. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis. AIDS Care. 2016;29:1–9.

Dolan K, Kite B, Black E, Aceijas C, Stimson GV. HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007;7(1):32–41.CrossRefPubMed

Telisinghe L, Charalambous S, Topp SM, Herce ME, Hoffmann CJ, Barron P, et al. HIV and tuberculosis in prisons in sub-Saharan Africa. Lancet. 2016;388(10050):1215–27.CrossRefPubMedPubMedCentral

UNAIDS. The Gap Report 2014. Joint United Nations programme on HIV/AIDS. Geneva; 2014.

United Nations Office on Drugs and Crime; Joint United Nations Programme on HIV/AIDS; The World Bank. HIV and Prisons in sub-Saharan Africa: opportunities for action. Vienna; 2007.

United Nations office on drugs and crime; Joint United Nations Programme on HIV/AIDS. Women and HIV in prison settings. Austria; 2008.

Beyrer C, Kamarulzaman A, McKee M. Prisoners, prisons, and HIV: time for reform. Lancet. 2016;388(10049):1033–5.CrossRefPubMed

10.

The Correctional Investigator Canada. Office of the correctional investigator annual report 2014–2015. 2015.

11.

Poulin C, Alary M, Lambert G, Godin G, Landry S, Gagnon H, et al. Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons. Can Med Assoc J. 2007;177(3):252–6.CrossRef

12.

Carter A, Eun Min J, Chau W, Lima VD, Kestler M, Pick N, et al. Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000–2010). Sluis-Cremer N, editor. PLoS ONE. 2014;9(3):92334.CrossRef

13.

Hogg RS, Milloy M-J, Kerr T, Zhang R, Guillemi S, Hogg RS, et al. Rates of disease progression by baseline CD4 Cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286(20):2568.CrossRefPubMed

14.

Lichtenstein B. Domestic violence in barriers to health care for HIV-positive women. AIDS Patient Care STDs. 2006;20(2):122–32.CrossRefPubMed

15.

Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16(8):2091–100.CrossRefPubMed

16.

Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003;18(4):248–57.CrossRefPubMedPubMedCentral

17.

Logie CH, James LL, Tharao W, Loutfy MR. HIV, gender, race, sexual orientation, and sex work a qualitative study of intersectional stigma experienced by HIV-positive women in Ontario. Daniels K, editor. PLoS Med. 2011;8(11):e1001124.CrossRefPubMedPubMedCentral

18.

Aziz M, Smith KY. Challenges and successes in linking HIV-infected women to care in the united states. Clin Infect Dis. 2011;52(SUPPL. 2):231–7.CrossRef

19.

Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.CrossRefPubMedPubMedCentral

20.

Spaulding AC, Messina LC, Kim BI, Chung K-W, Lincoln T, Teixeira P, et al. Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. AIDS Behav. 2013;17(S2):203–11.CrossRef

21.

Zelenev A, Marcus R, Kopelev A, Cruzado-Quinones J, Spaulding A, Desabrais M, et al. Patterns of homelessness and implications for HIV health after release from jail. AIDS Behav. 2013;17(Suppl 2):181–94.CrossRef

22.

Booker CA, Flygare CT, Solomon L, Ball SW, Pustell MR, Bazerman LB, et al. Linkage to HIV care for jail detainees: findings from detention to the first 30 days after release. AIDS Behav. 2013;17(SUPPL. 2):128–36.CrossRef

23.

Springer SA, Altice FL, Brown SE, Di Paola A. Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system. Drug Alcohol Depend. 2015;157:158–65.CrossRefPubMedPubMedCentral

24.

Springer SA, Qiu J, Saber-Tehrani AS, Altice FL. Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS ONE. 2012;7(5):e38335.CrossRefPubMedPubMedCentral

25.

Wang EA, McGinnis KA, Long JB, Akgün KM, Edelman EJ, Rimland D, et al. Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherence. Am J Addict. 2015;24(2):178–84.CrossRefPubMedPubMedCentral

26.

Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.CrossRefPubMedPubMedCentral

27.

Althoff AL, Zelenev A, Meyer JP, Fu J, Brown S-E, Vagenas P, et al. Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav. 2013;17(Suppl 2):156–70.CrossRefPubMedCentral

28.

Teixeira PA, Jordan AO, Zaller N, Shah D, Venters H. Health outcomes for HIV-infected persons released from the New York city jail system with a transitional care-coordination plan. Am J Public Health. 2015;105(2):351–7.CrossRefPubMedPubMedCentral

29.

Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health. 2014;104(3):434–41.CrossRefPubMedPubMedCentral

30.

Beckwith C, Castonguay BU, Trezza C, Bazerman L, Patrick R, Cates A, et al. Gender differences in HIV care among criminal justice-involved persons: baseline data from the CARE+ correction study. PLoS ONE. 2017;12(1):1–15.CrossRef

31.

Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.CrossRefPubMedPubMedCentral

32.

Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.CrossRefPubMed

33.

Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923–36.CrossRefPubMed

34.

Kennedy MC, Kerr T, Mcneil R, Parashar S, Montaner J, Wood E, et al. Residential eviction and risk of detectable plasma HIV-1 RNA viral load among HIV-positive people who use drugs. AIDS Behav. 2017;21(3):678–87.CrossRefPubMedPubMedCentral

35.

Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.CrossRefPubMed

36.

Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982;13:290.CrossRef

37.

Nosyk B, Montaner JSG, Colley G, Lima VD, Chan K, Heath K, et al. The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study. Lancet Infect Dis. 2014;14(1):40–9.CrossRefPubMed

38.

Montaner JSG, Lima VD, Harrigan PR, Lourenço L, Yip B, Nosyk B, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. Sluis-Cremer N, editor. PLoS ONE. 2014;9(2):e87872.CrossRefPubMedPubMedCentral

39.

Public Health Agency of Canada. Summary: Estimates of HIV Incidence, Prevalence and proportion undiagnosed in Canada, 2014. 2015.

40.

Correctional Service of Canada. Summary of Emerging Findings from the 2007 National Inmate Infectious Diseases and Risk-Behaviours Survey. 2010.

41.

Public Health Agency of Canada. HIV and AIDS in Canada: Surveillance Report to December 31, 2013. 2014.

42.

Statistics Canada. Aboriginal peoples in Canada: first nations people. Census Program: Metis and Inuit; 2011.

43.

Avery AK, Ciomcia RW, Lincoln T, Desbrais M, Jordan AO, Rana AI, et al. Jails as an opportunity to increase engagement in HIV care: findings from an observational cross-sectional study. AIDS Behav. 2013;17(S2):137–44.CrossRef

44.

Goldenberg SM, Montaner J, Duff P, Nguyen P, Dobrer S, Guillemi S, et al. Structural barriers to antiretroviral therapy among sex workers living with HIV: findings of a longitudinal study in Vancouver. Can AIDS Behav. 2016;20(5):977–86.CrossRefPubMed

45.

Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R, et al. Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011;203(9):1215–21.CrossRefPubMedPubMedCentral

46.

Lin S, Martin R, Milloy M, Carter A, Patterson S, Webster K, et al. Factors associated with ever and recent incarceration experience among women living with HIV in Canada. AIDS 2016, Abstr Number THPED307. 2016;.

47.

Roberson DW, White BL, Fogel CI. Factors influencing adherence to antiretroviral therapy for HIV-infected female inmates. J Assoc Nurses AIDS Care. 2009;20(1):50–61.CrossRefPubMedPubMedCentral

48.

Culbert GJ. Violence and the perceived risks of taking antiretroviral therapy in US jails and prisons. Int J Prison Health. 2014;10(2):94–110.CrossRefPubMedPubMedCentral

49.

Belenko S, Dembo R, Copenhaver M, Hiller M, Swan H, Albizu Garcia C, et al. HIV stigma in prisons and jails: results from a staff survey. AIDS Behav. 2016;20(1):71–84.CrossRefPubMedPubMedCentral

50.

Ministry of Public Safety and Solicitor General BC. A Profile of BC corrections: reduce reoffending, protect communities (2017). 2017.

51.

Pick N, Kinvig K, Quaia C, Paquette T, Slater A, Kestler M, et al. Bridging the Gap : an Oak Tree Clinic interdisciplinary outreach Approach to HIV care at alouette correctional centre for women in British Columbia. In: 4th International Workshop on HIV & Women. Washington, DC; 2014.

52.

Pai NP, Estes M, Moodie EEM, Reingold AL, Tulsky JP. The impact of antiretroviral therapy in a cohort of HIV infected patients going in and out of the San Francisco county jail. PLoS ONE. 2009;4(9):e7115.CrossRefPubMed

53.

Lincoln T, Kennedy S, Tuthill R, Roberts C, Conklin TJ, Hammett TM. Facilitators and barriers to continuing healthcare after jail: a community-integrated program. J Ambul Care Manage. 2006;29(1):2–16.CrossRefPubMed

54.

Martin R, Buxton J, Smith M, Hislop G. The scope of the problem: the health of incarcerated women in BC. BC Med J. 2012;54(10):502.

55.

Duff P, Goldenberg S, Deering K, Montaner J, Nguyen P, Dobrer S, et al. Barriers to viral suppression among female sex workers. JAIDS J Acquir Immune Defic Syndr. 2016;73(1):83–90.CrossRefPubMed

56.

Fu JJ, Herme M, Wickersham JA, Zelenev A, Althoff A, Zaller ND, et al. Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav. 2013;17(Suppl 2):145–55.CrossRef

57.

Espino SR, Fletcher J, Gonzalez M, Precht A, Xavier J, Matoff-Stepp S. Violence screening and viral load suppression among HIV-positive women of color. AIDS Patient Care STDS. 2015;29(S1):S36–41.CrossRefPubMedPubMedCentral

58.

Donastorg Y, Barrington C, Perez M, Kerrigan D, Baral S, Beyrer C, et al. Abriendo Puertas baseline findings from an integrated intervention to promote prevention, treatment and care among FSW Living with HIV in the dominican republic. Tang JW, editor. PLoS ONE. 2014;9(2):88157.CrossRef

59.

Hatcher AM, Smout EM, Turan JM, Christofides N, Stöckl H. Intimate partner violence and engagement in HIV care and treatment among women. AIDS. 2015;29(16):2183–94.CrossRefPubMed

60.

Machtinger EL, Haberer JE, Wilson TC, Weiss DS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav. 2012;16(8):2160–70.CrossRefPubMed

61.

Natukunda J, Kirabira P, Ing K, Ong C, Shibanuma A, Jimba M. Virologic failure in HIV-positive adolescents with perfect adherence in Uganda: a cross-sectional study. Trop Med Health. 2019;47:8.CrossRefPubMedPubMedCentral

62.

Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, et al. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011;11(2):167–74.CrossRefPubMedPubMedCentral

Titel: Recent Incarceration as a Primary Barrier to Virologic Suppression Among Women Living with HIV: Results from a Longitudinal Community-Based Cohort in a Canadian Setting
verfasst von: Margaret Erickson
Neora Pick
Flo Ranville
Melissa Braschel
Mary Kestler
Karen Kinvig
Andrea Krüsi
Kate Shannon
SHAWNA Project
Publikationsdatum: 19.07.2019
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2020
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-019-02606-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Perceptions of Community and Clinic-Based Adherence Clubs for Patients Stable on Antiretroviral Treatment: A Mixed Methods Study

Impact of an HIV Care Coordination Program on the Timeliness of Viral Suppression and Immune Recovery Among Clients Newly Diagnosed with HIV

How Do Treatment Priorities Differ Between Patients in HIV Care and Their Providers? A Mixed-Methods Study

Neighborhood Matters: Impact on Time Living with Detectable Viral Load for New Adult HIV Diagnoses in South Carolina

Behavioral and Cardiovascular Effects of a Behavioral Weight Loss Program for People Living with HIV